JP2022058064A5 - - Google Patents

Download PDF

Info

Publication number
JP2022058064A5
JP2022058064A5 JP2020175650A JP2020175650A JP2022058064A5 JP 2022058064 A5 JP2022058064 A5 JP 2022058064A5 JP 2020175650 A JP2020175650 A JP 2020175650A JP 2020175650 A JP2020175650 A JP 2020175650A JP 2022058064 A5 JP2022058064 A5 JP 2022058064A5
Authority
JP
Japan
Prior art keywords
inhibitor
phagocytosis
polyphenol compound
actin reorganization
inhibitor according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2020175650A
Other languages
English (en)
Japanese (ja)
Other versions
JP7680661B2 (ja
JP2022058064A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2020175650A priority Critical patent/JP7680661B2/ja
Priority claimed from JP2020175650A external-priority patent/JP7680661B2/ja
Publication of JP2022058064A publication Critical patent/JP2022058064A/ja
Publication of JP2022058064A5 publication Critical patent/JP2022058064A5/ja
Application granted granted Critical
Publication of JP7680661B2 publication Critical patent/JP7680661B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2020175650A 2020-09-30 2020-09-30 アクチン再編成阻害剤、ファゴサイトーシス阻害剤、該阻害剤を含有するシミ形成抑制剤、並びに該抑制剤を含有する皮膚外用剤 Active JP7680661B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2020175650A JP7680661B2 (ja) 2020-09-30 2020-09-30 アクチン再編成阻害剤、ファゴサイトーシス阻害剤、該阻害剤を含有するシミ形成抑制剤、並びに該抑制剤を含有する皮膚外用剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2020175650A JP7680661B2 (ja) 2020-09-30 2020-09-30 アクチン再編成阻害剤、ファゴサイトーシス阻害剤、該阻害剤を含有するシミ形成抑制剤、並びに該抑制剤を含有する皮膚外用剤

Publications (3)

Publication Number Publication Date
JP2022058064A JP2022058064A (ja) 2022-04-11
JP2022058064A5 true JP2022058064A5 (enExample) 2023-12-21
JP7680661B2 JP7680661B2 (ja) 2025-05-21

Family

ID=81111328

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2020175650A Active JP7680661B2 (ja) 2020-09-30 2020-09-30 アクチン再編成阻害剤、ファゴサイトーシス阻害剤、該阻害剤を含有するシミ形成抑制剤、並びに該抑制剤を含有する皮膚外用剤

Country Status (1)

Country Link
JP (1) JP7680661B2 (enExample)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002519312A (ja) * 1998-06-30 2002-07-02 エイボン プロダクツ インコーポレーテッド 皮膚美白組成物
US7314634B2 (en) * 2002-02-22 2008-01-01 Steven Hernandez Use of polyphenols to treat skin conditions
JP2004175688A (ja) * 2002-11-25 2004-06-24 Nichirei Corp 美白剤及び化粧料
KR20120089407A (ko) * 2010-12-17 2012-08-10 계명대학교 산학협력단 홍차 추출물을 유효성분으로 포함하는 피부 상태 개선용 조성물
EP3682865B1 (en) * 2019-01-15 2026-04-29 Amorepacific Corporation Use of a green tea extract which has modified amounts of ingredients for skin-whitening or preventing or improving skin wrinkles
CN109833276B (zh) * 2019-04-01 2022-01-11 合肥卡迪尔生物科技有限公司 一种美白面膜及其制备方法

Similar Documents

Publication Publication Date Title
Ma et al. Flavonoids and their therapeutic applications in skin diseases
JP2009535417A5 (enExample)
WO2013085553A3 (en) Oxidative dyeing compositions comprising an 1-hexyl/heptyl-4,5-diaminopyrazole and a benzo[1,3]dioxol-5-ylamine and derivatives thereof
JP2023532111A5 (enExample)
BR112014031060A2 (pt) composto de fórmula 1a; composição farmacêutica; uso do composto; método para tratamento de infecção fúngica em um paciente; produto de proteção de planta; método para tratamento de infecção fúngica em uma planta; produto de tratamento de edifício antifúngico; método para tratamento de um edifício; e composto para uso
ES2050074A1 (es) Composicion cosmetica para el aclarado de la piel y procedimiento para su obtencion.
KR101861347B1 (ko) 여러 기원의 말초 궤양 치료를 위한 조성물
MY197901A (en) Composition containing camellia sinensis extract
US20090258098A1 (en) Penetrating carrier, antifungal composition using the same and method for treatment of dermatophyte infections
EP4599892A3 (en) Boronic acid derivatives and therapeutic uses thereof
DE50001610D1 (de) Antioxidative hautpflegemittel
RU2016107746A (ru) Средство, способствующее абсорбции гидрокситирозола и его производных in vivo, и применение такого средства
HK1222337A1 (zh) 用於施加药物活性成分或化妆品活性成分的局部组合物和载体
RU2018137684A (ru) Косметические композиции для защиты от веществ, загрязняющих воздух
Ghimeray et al. Evaluation of antioxidant and anti-inflammatory effect of Rhododendron brachycarpum extract used in skin care product by in vitro and in vivo test
AR108437A1 (es) Agente externo cutáneo para mejorar las arrugas de la piel que comprende un extracto de germen de trigo fermentado
MY156731A (en) NOVEL ANTIFUNGAL 5,6-DIHYDRO-4-[(DIFLUOROETHYL)PHENYL]-4H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE AND 4-(DIFLUOROETHYL)PHENYL-6H-PYRROLO[1,2-a][1,4]BENZODIAZEPINE DERIVATIVES
JP6051055B2 (ja) 皮膚外用組成物
WO2018237135A3 (en) PROCESS FOR THE PREPARATION OF A NORMALIZED COMPOSITION OF ARJUNOGLUCOSIDE FROM THE BARK OF TERMINALIA ARJUNA
KR102696318B9 (ko) 이소퀴놀린 유도체 화합물을 유효성분으로 포함하는 미토콘드리아 기능이상으로 인한 질환의 예방 또는 치료용 조성물
EP4427733A4 (en) NOVEL COMPOSITION WITH NEPETA CARARIA-DERIVED EXOSOMES AS ACTIVE INGREDIENT
JP2022058063A5 (enExample)
CL2021002374A1 (es) Tratamiento de fibromas con vitamina d y un agente tal como galato de epigalocatequina (egcg)
WO2008005577A3 (en) Compositions of polyphenols and methods of use
Ștefan et al. Flavonoids–An amazing group of compounds with potent antimicrobial properties